Bernd R. Seizinger, Director at Aprea Therapeutics, Inc. (APRE), bought 10,097 shares at $3.68 ($37K) on 2023-06-07, disclosed to the SEC on 2023-06-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.63 | 4,068 | $15K | 40.0% |
| 2 | $3.68 | 6,029 | $22K | 60.0% |
| Total | $3.66 avg | 10,097 | $37K | 100% |
| Filing → |
| APRE | BUY | 2024-10-15 | $27K | — | Filing → |
| APRE | BUY | 2024-03-14 | $100K | — | Filing → |
| APTO | BUY | 2023-09-25 | $53K | — | Filing → |